Literature DB >> 7856550

Histologic grading of breast cancer. Let's do it.

D L Page, I O Ellis, C W Elston.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7856550     DOI： 10.1093/ajcp/103.2.123

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  7 in total

1.  Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERα-GREB1 Transcriptional Axis.

Authors:  Zhao Zhang; Mauro E Cenciarini; Cecilia J Proietti; Yanming Wu; Matias Amasino; Tao Hong; Mei Yang; Yiji Liao; Huai-Chin Chiang; Virginia G Kaklamani; Rinath Jeselsohn; Ratna K Vadlamudi; Tim Hui-Ming Huang; Rong Li; Carmine De Angelis; Xiaoyong Fu; Patricia V Elizalde; Rachel Schiff; Myles Brown; Kexin Xu
Journal:  Cancer Res       Date:  2017-12-06       Impact factor: 12.701

2.  Malignant phyllodes tumour with liposarcomatous differentiation, invasive tubular carcinoma, and ductal and lobular carcinoma in situ: case report and review of the literature.

Authors:  Mardiana Abdul Aziz; Frank Sullivan; Michael J Kerin; Grace Callagy
Journal:  Patholog Res Int       Date:  2010-07-05

3.  Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.

Authors:  Ossama Tawfik; Bruce F Kimler; Marilyn Davis; Christopher Stasik; Sue-Min Lai; Matthew S Mayo; Fang Fan; John K Donahue; Ivan Damjanov; Patricia Thomas; Carol Connor; William R Jewell; Holly Smith; Carol J Fabian
Journal:  Virchows Arch       Date:  2007-04-26       Impact factor: 4.064

4.  Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer.

Authors:  Roxana Schillaci; Pablo Guzmán; Florencia Cayrol; Wendy Beguelin; María C Díaz Flaqué; Cecilia J Proietti; Viviana Pineda; Jorge Palazzi; Isabel Frahm; Eduardo H Charreau; Esteban Maronna; Juan C Roa; Patricia V Elizalde
Journal:  BMC Cancer       Date:  2012-02-22       Impact factor: 4.430

5.  Variation in breast cancer grading in 1,636 resections assessed using control charts and in silico kappa.

Authors:  Jinesa Moodley; Phillip Williams; Gabriela Gohla; Pierre Major; Michael Bonert
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

6.  Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial.

Authors:  Hitoshi Tsuda; Masafumi Kurosumi; Futoshi Akiyama; Shinji Ohno; Shigehira Saji; Norikazu Masuda; Akihiko Shimomura; Nobuaki Sato; Shintaro Takao; Shozo Ohsumi; Yutaka Tokuda; Hideo Inaji; Toru Watanabe
Journal:  Breast Cancer       Date:  2022-04-18       Impact factor: 3.307

7.  Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.

Authors:  María C Díaz Flaqué; Natalia M Galigniana; Wendy Béguelin; Rocío Vicario; Cecilia J Proietti; Rosalía Russo; Martín A Rivas; Mercedes Tkach; Pablo Guzmán; Juan C Roa; Esteban Maronna; Viviana Pineda; Sergio Muñoz; María Mercogliano; Eduardo H Charreau; Patricio Yankilevich; Roxana Schillaci; Patricia V Elizalde
Journal:  Breast Cancer Res       Date:  2013-12-17       Impact factor: 6.466
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.